Skip to main content
AARD logo
AARD
(NASDAQ)
Aardvark Therapeutics, Inc.
$5.06-- (--)
Loading... - Market loading

Aardvark Therapeutics, Inc. (AARD) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Aardvark Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy
Based on 6 unique analysts
Medium Confidence1.0:1 Buy/Sell

Average Price Target

$5.00
1.19% Downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AARD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Andy Hsieh
William Blair
BuyReiterates
-
Jeet Mukherjee
BTIG
HoldDowngrades
-
Tazeen Ahmad
BofA Securities
SellDowngrades
$4.00
William Wood
B Riley
BuyMaintains
$8.00 $7.00
Michael Ulz
Morgan Stanley
SellDowngrades
$7.00 $3.00
Brian Abrahams
RBC Capital
HoldMaintains
$6.00

Frequently Asked Questions

What is the analyst consensus rating for AARD?

The analyst consensus rating for AARD is "Buy" based on 6 analyst recommendations.

What is the average price target for AARD?

The average 12-month price target for AARD is $5.00, representing a downside of 1.2% from the current price of $5.06.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.